Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients

BACKGROUND: Studies show that alemtuzumab, a potent lymphocyte-depleting agent, is well tolerated in pediatric renal transplantation. We report on the use of alemtuzumab induction in highly HLA sensitized (HS) pediatric kidney transplant patients. METHODS: Fifty pediatric renal transplants were perf...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transplantation
Main Authors: Kim, Irene K., Choi, Jua, Vo, Ashley A., Kang, Alexis, Patel, Mitasha, Toyoda, Mieko, Mirocha, James, Kamil, Elaine S., Cohen, J. Louis, Louie, Sabrina, Galera, Odette, Jordan, Stanley C., Puliyanda, Dechu P.
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer 2017
Assuntos:
Original Clinical Science—General
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7228615/
https://ncbi.nlm.nih.gov/pubmed/27495773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0000000000001416
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados